12:00 AM
 | 
Jul 16, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Aquinox Pharmaceuticals Inc.

Vancouver, B.C.

Technology: Small molecules that agonize or antagonize SH2-containing inositol phosphatase (SHIP) and SHIP-2

Disease...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >